Changming et.al have reported that the overexpressed CCL5 was a risk factor for the pathogenesis of PAH, and CCL5 could exert vasoconstriction and remodel effects on the lung tissue in PAH [41]. Here, CCL5 is linked to pulmonary arterial hypertension.